Skip to main content
Premium Trial:

Request an Annual Quote

Symyx Technologies Buys MDL Informatics Business from Elsevier for $123M

NEW YORK (GenomeWeb News) - Symyx Technologies said today that it will acquire MDL Information Systems from Elsevier for $123 million in cash.
 
Symyx, based in Santa Clara, Calif., is a provider of electronic lab notebooks as well as other scientific decision-support software. The acquisition will provide it with MDL's full suite of informatics and database tools, including its ISIS and Isentris platforms, MDL Draw, MDL Direct, the Available Chemicals Directory, and DiscoveryGate.
 
The acquisition is expected to close in the fourth quarter of 2007. Symyx said the combined software and database operations are expected to reach around $100 million in revenues in 2008.
 
Symyx said that MDL currently has more than 1,000 customers and around 50,000 users for its content and software.
 
Isy Goldwasser, Symyx's chief executive officer, said that MDL is an “ideal strategic complement” to the company’s existing businesses, “as our market leadership in tools and research services will now be joined by expanded offerings in a substantially strengthened Symyx software business.”
 
Symyx said it plans to work closely with Elsevier as "part of a continuing strategic relationship to support existing and new customers."

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.